Combined Modality Treatment of Anal Carcinoma
نویسندگان
چکیده
منابع مشابه
Combined Modality Treatment of Anal Carcinoma.
Within the framework of two phase III clinical trials, the superior results of concomitant chemotherapy and radiotherapy in the treatment of patients with locally advanced anal carcinoma were demonstrated. A further phase III clinical trial showed that the role of mitomycin C as part of the concomitant chemotherapy in combination with 5-fluorouracil appeared to be essential in obtaining a highe...
متن کاملLong term outcome after combined modality treatment for anal cancer
BACKGROUND The aim of the retrospective study was to evaluate the effectiveness and toxicity of radiochemotherapy in patients with squamous cell carcinoma of the anal canal treated at a single institution. PATIENTS AND METHODS Between 1/2003 and 9/2010, 84 patients were treated with radical radiochemotherapy at the Institute of Oncology Ljubljana, Slovenia. The treatment consisted of 3-dimens...
متن کاملManagement of persistent anal canal carcinoma after combined-modality therapy: a clinical review
Anal canal carcinoma is a rare gastro-intestinal cancer. Radiochemotherapy is the recommended primary treatment for patients with non-metastatic carcinoma; surgery is generally reserved for persistent or recurrent disease. Follow-up and surveillance after primary treatment is paramount to classify patients in those with complete remission, persistent or progressive disease. Locally persistent d...
متن کاملCombined-Modality Treatment of Esophageal Cancer
Until recently, squamous-cell carcinoma comprised the vast majority of cases of esophageal cancer. However, the incidence of adenocarcinoma in white males has been rapidly increasing by approximately 10% per year for the past 10 years. This percentage increase in frequency exceeds that of all other cancers for that time period.[2,3] The prognosis for patients with either type of tumor histology...
متن کاملCombined modality treatment of Hodgkin's lymphoma.
Substantial clinical progress over the last decades has improved the first-line treatment and prognosis of patients with Hodgkin's lymphoma (HL). This success is mainly based on the introduction of combined modality treatment strategies including chemotherapy in all risk groups and important progress in radiation techniques. The knowledge emerging from numerous clinical trials as well as better...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Oncologist
سال: 1998
ISSN: 1083-7159,1549-490X
DOI: 10.1634/theoncologist.3-6-413